美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
0023-6498-01	0023-6498	HUMAN PRESCRIPTION DRUG	UBRELVY	ubrogepant	TABLET	ORAL	20191223	N/A	NDA	NDA211765	Allergan, Inc.	UBROGEPANT	50 mg/1	1 PACKET in 1 BOX (0023-6498-01) / 1 TABLET in 1 PACKET
0023-6498-04	0023-6498	HUMAN PRESCRIPTION DRUG	UBRELVY	ubrogepant	TABLET	ORAL	20191223	N/A	NDA	NDA211765	Allergan, Inc.	UBROGEPANT	50 mg/1	4 PACKET in 1 BOX (0023-6498-04) / 1 TABLET in 1 PACKET
0023-6498-10	0023-6498	HUMAN PRESCRIPTION DRUG	UBRELVY	ubrogepant	TABLET	ORAL	20191223	N/A	NDA	NDA211765	Allergan, Inc.	UBROGEPANT	50 mg/1	10 PACKET in 1 BOX (0023-6498-10) / 1 TABLET in 1 PACKET (0023-6498-02)
0023-6498-16	0023-6498	HUMAN PRESCRIPTION DRUG	UBRELVY	ubrogepant	TABLET	ORAL	20191223	N/A	NDA	NDA211765	Allergan, Inc.	UBROGEPANT	50 mg/1	16 PACKET in 1 BOX (0023-6498-16) / 1 TABLET in 1 PACKET (0023-6498-02)
0023-6498-30	0023-6498	HUMAN PRESCRIPTION DRUG	UBRELVY	ubrogepant	TABLET	ORAL	20191223	N/A	NDA	NDA211765	Allergan, Inc.	UBROGEPANT	50 mg/1	30 PACKET in 1 BOX (0023-6498-30) / 1 TABLET in 1 PACKET (0023-6498-02)
0023-6501-01	0023-6501	HUMAN PRESCRIPTION DRUG	UBRELVY	ubrogepant	TABLET	ORAL	20191223	N/A	NDA	NDA211765	Allergan, Inc.	UBROGEPANT	100 mg/1	1 PACKET in 1 BOX (0023-6501-01) / 1 TABLET in 1 PACKET
0023-6501-10	0023-6501	HUMAN PRESCRIPTION DRUG	UBRELVY	ubrogepant	TABLET	ORAL	20191223	N/A	NDA	NDA211765	Allergan, Inc.	UBROGEPANT	100 mg/1	10 PACKET in 1 BOX (0023-6501-10) / 1 TABLET in 1 PACKET (0023-6501-02)
0023-6501-16	0023-6501	HUMAN PRESCRIPTION DRUG	UBRELVY	ubrogepant	TABLET	ORAL	20191223	N/A	NDA	NDA211765	Allergan, Inc.	UBROGEPANT	100 mg/1	16 PACKET in 1 BOX (0023-6501-16) / 1 TABLET in 1 PACKET (0023-6501-02)
0023-6501-30	0023-6501	HUMAN PRESCRIPTION DRUG	UBRELVY	ubrogepant	TABLET	ORAL	20191223	N/A	NDA	NDA211765	Allergan, Inc.	UBROGEPANT	100 mg/1	30 PACKET in 1 BOX (0023-6501-30) / 1 TABLET in 1 PACKET (0023-6501-02)